β-Blockers, heart disease and COPD: current controversies and uncertainties
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-Blockers, heart disease and COPD: current controversies and uncertainties
Authors
Keywords
-
Journal
THORAX
Volume 72, Issue 3, Pages 271-276
Publisher
BMJ
Online
2016-12-08
DOI
10.1136/thoraxjnl-2016-208412
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
- (2016) Surya P Bhatt et al. BMJ Open
- Cardiovascular morbidity and the use of inhaled bronchodilators
- (2016) Nicholas Anthonisen International Journal of Chronic Obstructive Pulmonary Disease
- Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease
- (2015) Suzi Hong et al. BRAIN BEHAVIOR AND IMMUNITY
- Role of beta-blockers in patients with COPD: current perspective
- (2015) Mario Malerba et al. DRUG DISCOVERY TODAY
- Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies
- (2015) Zhengming Chen et al. LANCET
- The Asthma–COPD Overlap Syndrome
- (2015) Dirkje S. Postma et al. NEW ENGLAND JOURNAL OF MEDICINE
- β-Blockers are associated with a reduction in COPD exacerbations
- (2015) Surya P Bhatt et al. THORAX
- Is It Time to Beta Block the Septic Patient?
- (2015) Philip Pemberton et al. Biomed Research International
- -Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
- (2015) P. Andell et al. Journal of the American Heart Association
- COPD in patients with stable heart failure in the primary care setting
- (2015) Mark Valk et al. International Journal of Chronic Obstructive Pulmonary Disease
- Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
- (2014) Kim Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multicentric study on the beta-blocker use and relation with exacerbations in COPD
- (2014) Luis Puente-Maestu et al. RESPIRATORY MEDICINE
- Neuroendocrine regulation of inflammation
- (2014) Caroline J. Padro et al. SEMINARS IN IMMUNOLOGY
- Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease
- (2013) Magnus P. Ekström et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- β-Blocker Use and Incidence of Chronic Obstructive Pulmonary Disease Exacerbations
- (2013) Michelle Z Farland et al. ANNALS OF PHARMACOTHERAPY
- β-adrenoceptor blockers and pulmonary function in the general population: the Rotterdam Study
- (2013) Daan W. Loth et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: An efficacy and safety analysis of SHIFT study
- (2013) L. Tavazzi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- β-Blockers and All-Cause Mortality in Adults with Episodes of Acute Bronchitis: An Observational Study
- (2013) Frans H. Rutten et al. PLoS One
- Effect of blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records
- (2013) J. K. Quint et al. BMJ-British Medical Journal
- Heart Rate-Lowering Efficacy and Respiratory Safety of Ivabradine in Patients with Obstructive Airway Disease
- (2012) Sebastian Majewski et al. American Journal of Cardiovascular Drugs
- Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
- (2012) Alvar Agustí et al. PLoS One
- Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension
- (2012) Mihaela S Stefan et al. THORAX
- β-Blockers for COPD inpatients
- (2012) Samy Suissa et al. THORAX
- Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease
- (2012) Paul Albert et al. THORAX
- Bronchodilator Reversibility in COPD
- (2011) Nicola A. Hanania et al. CHEST
- Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses
- (2011) Jillian G. Baker et al. FASEB JOURNAL
- Heart Failure and Chronic Obstructive Pulmonary Disease
- (2011) Nathaniel M. Hawkins et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease
- (2010) Frans H. Rutten ARCHIVES OF INTERNAL MEDICINE
- The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors
- (2010) Jillian G Baker BRITISH JOURNAL OF PHARMACOLOGY
- Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease
- (2010) Andrew Jabbour et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
- (2010) Karl Swedberg et al. LANCET
- Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
- (2010) Michael Böhm et al. LANCET
- Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care
- (2010) J. R. Feary et al. THORAX
- Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial
- (2009) Nathaniel M. Hawkins et al. EUROPEAN JOURNAL OF HEART FAILURE
- The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease
- (2009) Laura C.M. Boudestein et al. EUROPEAN JOURNAL OF HEART FAILURE
- Immeasurable Time Bias in Observational Studies of Drug Effects on Mortality
- (2008) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
- Outcomes for COPD pharmacological trials: from lung function to biomarkers
- (2008) M. Cazzola et al. EUROPEAN RESPIRATORY JOURNAL
- Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
- (2008) Kim Fox et al. LANCET
- Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
- (2008) Kim Fox et al. LANCET
- Lung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: Response by beta-agonist reversibility
- (2008) Eugene R. Bleecker et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Immortal Time Bias in Pharmacoepidemiology
- (2007) S. Suissa AMERICAN JOURNAL OF EPIDEMIOLOGY
- Use of blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
- (2007) M T Dransfield et al. THORAX
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started